- Product Details
Keywords
- Atorvastatin
- 110862-48-1
- C33H35FN2O5
Quick Details
- ProName: lower price Atorvastatin(110862-48-1)...
- CasNo: 110862-48-1
- Molecular Formula: C33H35FN2O5
- Appearance: white powder
- Application: used for research
- DeliveryTime: 3 days
- PackAge: aluminum foil bag
- Port: shenzhen
- ProductionCapacity: 1 Metric Ton/Day
- Purity: 99%min
- Storage: Store in cool, dry, ventilated place
- Transportation: by sea or by air
- LimitNum: 1 Gram
- Related Substances: N/A
- Residue on Ignition: N/A
- Heavy Metal: N/A
- Valid Period: one year
- N/A: N/A
Superiority
www.wolcase.com
Details
-
Atorvastatin 10-Trans (Atorvastatin Impurity AT10) Basic information
Product Name: Atorvastatin 10-Trans (Atorvastatin Impurity AT10)
Synonyms: [R-(R*,S*)-2-(4-Fluorophenyl)-,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt;Atorvastatin 10-Trans (Atorvastatin Impurity AT10);Atorvastatin Impurity AT10;(3S,5R)-Atorvastatin Sodium Salt;(3R,5S)-Atorvastatin Sodium Salt;(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-heptanoic Acid SodiuM Salt;(βS,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-heptanoic Acid SodiuM Salt;[R-(R*,S*)-2-(4-Fluorophenyl)-,d-dihydroxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-he
CAS: 131275-93-9
MF: C33H34FN2O5.Na
MW: 580.629
EINECS:
Product Categories: Impurities;Intermediates & Fine Chemicals;Pharmaceuticals;Aromatics;Chiral Reagents;Inhibitors;Pfizer compounds
Mol File: 131275-93-9.mol
Atorvastatin 10-Trans (Atorvastatin Impurity AT10) Structure
Atorvastatin 10-Trans (Atorvastatin Impurity AT10) Chemical Properties
mp 178-180°C
storage temp. Hygroscopic, -20°C Freezer, Under Inert Atmosphere
Safety Information
MSDS Information
Atorvastatin 10-Trans (Atorvastatin Impurity AT10) Usage And Synthesis
Chemical Properties Off-White Solid
Usage Atorvastatin impurity AT10 Trans
Usage Atorvastatin impurity in bulk drug and tablets.